SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001935979-23-000037
Filing Date
2023-05-31
Accepted
2023-05-31 07:03:46
Documents
13
Period of Report
2023-05-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20230531.htm   iXBRL 8-K 31701
2 EX-99.1 exhibit991biohavenprovides.htm EX-99.1 24888
  Complete submission text file 0001935979-23-000037.txt   203682

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20230531.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20230531_lab.xml EX-101.LAB 24799
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20230531_pre.xml EX-101.PRE 13043
7 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20230531_htm.xml XML 10934
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 23978908
SIC: 2834 Pharmaceutical Preparations